Aurora Cannabis (ACB) Liabilities from Discontinued Operations (2022 - 2024)

Aurora Cannabis (ACB) posted quarterly Liabilities from Discontinued Operations of 939041.42 for Q3 2024, up 6.5% on a QoQ basis from 881755.5 in Q2 2024.

Aurora Cannabis (ACB) Liabilities from Discontinued Operations (2022 - 2024) Analysis & Trends

Aurora Cannabis (ACB) has reported Liabilities from Discontinued Operations for 2 consecutive years, with 939041.42 the latest figure, recorded in Q3 2024.

  • Quarterly Liabilities from Discontinued Operations changed N/A year-over-year to 939041.42 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 939041.42 (changed N/A YoY) and the FY2022 annual result came in at 4732706.24, changed N/A from the prior year.
  • Liabilities from Discontinued Operations improved to 939041.42 in Q3 2024 per ACB's latest filing, from 881755.5 in the prior quarter.
  • Over the last five years, Liabilities from Discontinued Operations for ACB reached as high as 4696631.83 in Q2 2022 and fell as low as 881755.5 in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Aurora Cannabis 1.11 Bn 1.03 Bn 21.72 Mn

Historic Data

Download Data
DateValue
Sep 30, 2024 939,041.42
Sep 30, 2024 939,041.42
Jun 30, 2024 881,755.50
Jun 30, 2024 881,755.50
Dec 31, 2022 1.47 Mn
Dec 31, 2022 1.47 Mn
Sep 30, 2022 4.60 Mn
Sep 30, 2022 4.60 Mn
Jun 30, 2022 4.70 Mn
Jun 30, 2022 4.70 Mn
Mar 31, 2022 3.14 Mn
Mar 31, 2022 3.14 Mn